JSM 2011 Online Program
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Activity Details
|
|||
228 | Mon, 8/1/2011, 2:00 PM - 3:50 PM | CC-A205 | |
The Use of Historical Data Priors in the Design and Analysis of Clinical Trials — Topic Contributed Papers | |||
Biopharmaceutical Section , Section on Health Policy Statistics | |||
Organizer(s): David Ohlssen, Novartis | |||
Chair(s): David Ohlssen, Novartis | |||
2:05 PM | Evaluating Probability of Study Success Through Bayesian Evidence — Haoda Fu, Eli Lilly and Company | ||
2:25 PM | A Bayesian Adaptive Dose Selection Procedure with a Count Endpoint — Luca Pozzi, University of California at Berkeley ; Heinz Schmidli, Novartis Pharma AG ; Mauro Gasparini, Politecnico di Torino ; Amy Racine, Novartis | ||
2:45 PM | From Historical Data to Priors — Beat Neuenschwander, Novartis Pharma AG | ||
3:05 PM | Examples of Safety and Efficacy Analyses in Early Clinical Development Incorporating Historical Data — Neal Thomas, Pfizer Inc. | ||
3:25 PM | Discussant: Ram C. Tiwari, U.S. Food and Drug Administration/CDER/OTS/OB | ||
3:45 PM | Floor Discussion |
2011 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.